Camurus AB (CAMRF)
56.80
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Camurus Gross Profit Margin (Quarterly): 93.01% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 93.01% |
| June 30, 2024 | 92.85% |
| March 31, 2024 | 92.08% |
| December 31, 2023 | 91.30% |
| September 30, 2023 | 91.67% |
| June 30, 2023 | 95.70% |
| March 31, 2023 | 89.86% |
| December 31, 2022 | 89.56% |
| September 30, 2022 | 90.05% |
| June 30, 2022 | 88.94% |
| March 31, 2022 | 88.11% |
| December 31, 2021 | 84.59% |
| September 30, 2021 | 86.41% |
| June 30, 2021 | 85.07% |
| March 31, 2021 | 87.55% |
| December 31, 2020 | 88.18% |
| September 30, 2020 | 89.38% |
| June 30, 2020 | 94.59% |
| March 31, 2020 | 84.22% |
| December 31, 2019 | 61.34% |
| Date | Value |
|---|---|
| September 30, 2019 | 88.13% |
| June 30, 2019 | 83.37% |
| March 31, 2019 | 83.79% |
| December 31, 2018 | 49.56% |
| September 30, 2018 | 99.38% |
| June 30, 2018 | 83.36% |
| March 31, 2018 | 89.43% |
| December 31, 2017 | 86.20% |
| September 30, 2017 | |
| June 30, 2017 | 94.25% |
| March 31, 2017 | 99.82% |
| December 31, 2016 | 96.69% |
| September 30, 2016 | 98.21% |
| June 30, 2016 | 98.83% |
| March 31, 2016 | 99.69% |
| December 31, 2015 | 99.71% |
| September 30, 2015 | 99.65% |
| June 30, 2015 | |
| March 31, 2015 | 99.95% |
| December 31, 2014 | 99.91% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
61.34%
Minimum
Dec 2019
95.70%
Maximum
Jun 2023
88.22%
Average
89.47%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abliva AB | -- |
| Oncopeptides AB | -- |
| BioInvent International AB | -- |
| Hansa Biopharma AB | 76.62% |
| BioArctic AB | 90.35% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.41% |
| Return on Assets | 9.64% |
| Return on Invested Capital | 11.41% |
| Profit Margin (Quarterly) | 26.97% |
| Operating Margin (Quarterly) | 29.57% |
| Return on Net Operating Assets | 20.13% |